O-RAN-ALLIANCE
14.12.2022 18:47:40 CET | Business Wire | Press release
The O-RAN Global PlugFest Fall 2022 was successfully completed in 6 venues across Asia, Europe, and North America, with 106 participating companies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221214005850/en/
O-RAN ALLIANCE global PlugFests represent a major platform enabling efficient progress of the O-RAN ecosystem through well-organized testing and integration. O-RAN Global PlugFest Fall 2022 is the second O-RAN PlugFest this year. In combination with the Spring PlugFest, the 2022 O-RAN Global PlugFests span across 9 venues with 156 participants, of which many participated at more than one venue.
“Testing and integration at O-RAN PlugFests show increasing maturity of O-RAN technology in all regions,” said Linsheng Liao, O-RAN TIFG Co-chair and Senior Project Manager of CMRI. “Comparing the PlugFest results year to year, we are pleased to see major progress made by the O-RAN ecosystem in conformance and interoperability tests, as well as more advanced end-to-end and network automation scenarios. O-RAN PlugFests greatly contribute to developing commercially available O-RAN networks.”
O-RAN Global PlugFest Fall 2022 in Asia
PlugFest in Japan, hosted by NTT DOCOMO, KDDI, Rakuten Mobile, SoftBank, YRP and YRP R&D Promotion Committee took place at multiple sites in large metropolitan area. Activities focused on:
- Lab tests and field trials of latency assurance with Near-RT RIC for E2E network slicing
- Conformance, IOT, E2E testing, including Open Fronthaul and security verification
- Field tests of mmW backhaul system using O-RAN Fronthaul
- Multi-vendor vRAN integration
- Near-RT RIC demo with xApp and E2 nodes
- Open source demo realizing vRAN application deployment with OpenStack Tacker
In addition to the hosts, participants included AMD AECG, Anritsu, ComWorth, Dell Technologies, DKK, DZS, Fujitsu, HCL, Keysight Technologies, KYOCERA, NEC, NVIDIA, Red Hat, Spirent, TOYO, VIAVI Solutions and Wind River.
PlugFest in South Korea hosted by LG Uplus focused on:
- 5G O-RAN in-building field trial
- 5G O-RAN Lab validation
- Test scenarios including fronthaul conformance test, E2E test, analysis of fronthaul and midhaul interfaces
- Validation of RIC use case with xApp/rApp and the open interfaces (O1, A1, and E2)
In addition to the hosts, participants included Ciena, DELL Technologies, ETRI, Innowireless, Juniper Networks, Keysight Technologies and Viettel High Technology Industries.
PlugFest in South Korea hosted by SK Telecom focused on:
- Open Fronthaul interface conformance testing for O-DU and O-RU
- O-RAN specified interoperability testing between O-DU and O-RU
- Evaluation of O-RAN based private 5G systems through O-RAN specified E2E tests
- Performance and functional testing in live indoor environments
In addition to the hosts, participants included ETRI, Hewlett Packard Enterprise, HFR, Intel and Keysight Technologies.
O-RAN Global PlugFest Fall 2022 in Europe
Deutsche Telekom, EANTC, EURECOM, Orange, TIM, Vodafone and BT have teamed up together with Telecom Infra Project (TIP) to host the Joint European O-RAN & TIP PlugFest Fall 2022. The PlugFest was hosted in four European labs, namely EURECOM in Sophia Antipolis, i14y Lab in Berlin, Orange Lab in Paris and TIM Innovation Lab in Torino.
The joint PlugFest has demonstrated complementarities and synergies between O-RAN and TIP as well as between the labs.
Test scenarios focused on:
- Conformance testing of Open Fronthaul interface of O-RU and O-DU
- End-to-end multi-vendor integration with functional and performance testing
- xApps/rApps integration with Near/Non-RT RICs and xApps/rApps functional verification
- O-Cloud platform performance testing
In addition to the hosts, participants included Aarna Networks, Accelleran, ADVA Optical Networking, Analog Devices, Anritsu, Aspire Technology, Azcom Technology, Calnex Solutions, Capgemini Engineering, Dell Technologies, DZS, Fujitsu, Hewlett Packard Enterprise, highstreet technologies, JMA Wireless, Juniper Networks, Keysight Technologies, Mavenir, Microamp Solutions, MTI, NEC, Net AI, Nokia, Open Networking Foundation, Radisys, Red Hat, Rimedo Labs, Rohde & Schwarz, SIAE MICROELETTRONICA, SOLiD, Spirent, VIAVI Solutions, VMware and VoerEir.
O-RAN Global PlugFest Fall 2022 in North America
PlugFest in North America hosted by CableLabs at the Kyrio OTIC Lab focused on:
- Multi-vendor O-RAN end-to-end system under test, based on the O-RAN E2E test specification, demonstrating cell capacity for signaling and user-plane traffic load. Moreover, the Fronthaul delay impact on user peak throughput was measured using Fronthaul impairment emulators.
- Demonstration of O-CU interoperability, based on the O-RAN IOT test specifications, verified traffic scenarios across emulated F1 and Xn interfaces, as well as the open F1 and Xn protocol implementation. In addition, the O-CU demonstrated successful interoperability for F1AP and XnAP global, elementary, and mobility procedures.
- Near-RT RIC testing for conformance to the O-RAN E2 interface specification (E2AP, E2 SM, E2 SM RC, and E2 SM KPM procedures) were verified following the E2 test specification. Moreover, a QoS xApp was integrated and tested.
In addition to the hosts, participants included Calnex Solutions, Capgemini Engineering, Lumentum Holdings, Radisys Networks, Sunwave Communications, VIAVI Solutions and Xena Networks.
PocFest in North America hosted by UNH-IOL, hosted by AT&T and DISH, took place in four labs:
- University of New Hampshire InterOperability Lab
- TIP Community Lab at Meta, Menlo Park CA
- POWDER Lab and NSF PAWR SITE with the University of Utah
- COSMOS Lab and NSF PAWR SITE with the Rutgers University, Columbia University, NYU Wireless
Activities focused on testing of conformance and performance of O-RU devices, measurements of energy saving and efficiency, integration of AI/ML for resource pooling and slicing, testing of RIC, xApps, SMO, and end-to-end interoperability testing.
In addition to the hosts, participants included AMD, Anritsu, Calnex, DZS, Fujitsu, HCL, Intel, Keysight Technologies, NEC, Radisys, Rohde & Schwarz, VIAVI Solutions, VVDN, VMware, Vodafone, Wind River and Xena.
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 330 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information, please visit www.o-ran.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221214005850/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom